HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

Andrea De Luca, K. Theys, J. Vercauteren, J. Snoeck, M. Zazzi, R. J. Camacho, C. Torti, E. Schülter, B. Clotet, A. De Luca, Z. Grossman, D. Struck, A. M. Vandamme, A. B. Abecasise

Risultato della ricerca: Contributo in rivistaArticolo in rivista

32 Citazioni (Scopus)

Abstract

Subtype-dependent selection of HIV-1 reverse transcriptase resistance mutation K65R was previously observed in cell culture and small clinical investigations. We compared K65R prevalence across subtypes A, B, C, F, G, and CRF02_AG separately in a cohort of 3,076 patients on combination therapy including tenofovir. K65R selection was significantly higher in HIV-1 subtype C. This could not be explained by clinical and demographic factors in multivariate analysis, suggesting subtype sequence-specific K65R pathways.
Lingua originaleEnglish
pagine (da-a)1053-1056
Numero di pagine4
RivistaAntimicrobial Agents and Chemotherapy
Volume57
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • mutation
  • subtype

Fingerprint Entra nei temi di ricerca di 'HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir'. Insieme formano una fingerprint unica.

Cita questo